"A leader in real-world evidence, CorEvitas provides regulatory-grade data to pharmaceutical companies to power the drug development lifecycle. CorEvitas' data are unmatched in depth and completeness across clinical measures and patient reported outcomes."

During the past decade, Corrona, LLC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Corrona, LLC" are "Atopic Dermatitis" (1 trials), "Inflammatory Bowel Diseases" (1 trials), "Multiple Sclerosis" (1 trials), "Neuromyelitis Optica Spectrum Disorder" (1 trials) and "Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)" (1 trials). Many other conditions were trialed in "Corrona, LLC" in a lesser frequency.

Most popular intervention types in "Corrona, LLC" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Observational Non-Interventional Registry" (1 trials). Other intervention names were less common.

The vast majority of trials in "Corrona, LLC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Corrona, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were undefined completed trials in Corrona, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Corrona, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".